IF
NASDAQ · IFRX
InflaRx N.V.
Healthcare · Biotechnology
$1.58
Down-$0.10 (-5.95%)
Updated Oct 7, 2026, 2:51 AM
SID Score
4.2/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 69.1M
- P/E ratio
- -1.3
- Dividend yield
- 0.00%
- 52-week range
- $0.80 – $2.95
- Volume
- 720.67K
- Avg. volume
- 2.87M
Price performance · IFRX
IFRX price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 6, 2026
IFRX closed at $1.58 after 21 trading sessions, down 27.19% for the selected period.
- Last close
- $1.58
- Period change
- -27.19%
- Period low
- $1.58
- Period high
- $2.17
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 6, 2026 | $1.69 | $1.78 | $1.565 | $1.58 | 720.67K |
| Oct 5, 2026 | $1.70 | $1.72 | $1.65 | $1.68 | 701.01K |
| Oct 2, 2026 | $1.74 | $1.80 | $1.72 | $1.72 | 422.16K |
| Oct 1, 2026 | $1.83 | $1.856 | $1.71 | $1.71 | 369.96K |
| Sep 30, 2026 | $1.87 | $1.89 | $1.80 | $1.80 | 302.5K |
| Sep 29, 2026 | $1.83 | $1.89 | $1.80 | $1.85 | 268.4K |
| Sep 28, 2026 | $1.88 | $1.9544 | $1.80 | $1.82 | 426.39K |
| Sep 25, 2026 | $1.94 | $2.04 | $1.87 | $1.89 | 399.9K |
| Sep 24, 2026 | $1.97 | $2.02 | $1.89 | $1.93 | 510.19K |
| Sep 23, 2026 | $2.08 | $2.09 | $1.96 | $1.96 | 564.76K |
| Sep 22, 2026 | $2.12 | $2.19 | $2.041 | $2.08 | 571.27K |
| Sep 21, 2026 | $2.11 | $2.19 | $2.065 | $2.12 | 345.15K |
| Sep 18, 2026 | $2.07 | $2.11 | $2.0254 | $2.09 | 292.68K |
| Sep 17, 2026 | $2.05 | $2.10 | $1.98 | $2.06 | 657.95K |
| Sep 16, 2026 | $2.02 | $2.0689 | $1.99 | $2.04 | 821.21K |
| Sep 15, 2026 | $2.12 | $2.165 | $1.99 | $2.02 | 579.6K |
| Sep 14, 2026 | $2.15 | $2.20 | $2.10 | $2.12 | 545.79K |
| Sep 11, 2026 | $2.07 | $2.11 | $2.04 | $2.09 | 334.15K |
| Sep 10, 2026 | $2.05 | $2.07 | $1.98 | $2.05 | 613.48K |
| Sep 9, 2026 | $2.15 | $2.15 | $2.05 | $2.09 | 759.75K |
| Sep 8, 2026 | $2.19 | $2.26 | $2.11 | $2.17 | 408.9K |
Latest IFRX news
The latest Smart Investors Daily articles mentioning IFRX.
Stock researchResearch & News · Competitors
Company
Market Activity
Research & News
Loading stock research…
